Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | 240,000 | reported | 05 Jan 2026 | tx 1+240,000 |
| Immunovant, Inc. | 129,365 | reported | 19 Mar 2021 | tx 7+1,143,330 |
| Akebia Therapeutics, Inc. | 96,332 | reported | 11 Apr 2019 | tx 7+466,200−13,068 |
| Celldex Therapeutics, Inc. | 16,500 | reported | 05 Jun 2025 | tx 3+50,100 |
| First Tracks Biotherapeutics, Inc. | 15,000 | reported | 12 May 2026 | tx 10+125,465 |
| ANAPTYSBIO, INC | 4,000 | reported | 06 Jan 2026 | tx 16+92,193−11,864 |
| Avalo Therapeutics, Inc. | 1,043 | reported | 31 Dec 2025 | tx 3+42,815 |
| Provention Bio, Inc. | 0 | reported | 27 Apr 2023 | tx 2+66,000−66,000 |
| ChemoCentryx, Inc. | 0 | reported | 20 Oct 2022 | tx 28+154,981−152,093 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 May 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 12 May 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 42,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 10,600 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 8,015 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 5,500 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 1,300 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 6,030 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 4,000 | 0.00 USD | deriv |
| 06 Jan 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 4,000 | 0.00 USD | deriv |
| 06 Jan 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 5,500 | 0.00 USD | deriv |
| 05 Jan 2026 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 240,000 | 0.00 USD | deriv |
| 31 Dec 2025 | GRANT_AWARD | Avalo Therapeutics, Inc. | 1,043 | 14.74 USD | deriv |
| 30 Sept 2025 | GRANT_AWARD | Avalo Therapeutics, Inc. | 1,572 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Avalo Therapeutics, Inc. | 40,200 | 0.00 USD | deriv |
| 15 Jun 2025 | EXERCISE | ANAPTYSBIO, INC | 7,330 | 0.00 USD | |
| 15 Jun 2025 | EXERCISE | ANAPTYSBIO, INC | 6,030 | 0.00 USD | deriv |
| 15 Jun 2025 | EXERCISE | ANAPTYSBIO, INC | 1,300 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Celldex Therapeutics, Inc. | 16,500 | 0.00 USD | deriv |
| 07 Jan 2025 | GRANT_AWARD | ANAPTYSBIO, INC | 16,510 | 0.00 USD | deriv |
| 07 Jan 2025 | GRANT_AWARD | ANAPTYSBIO, INC | 6,030 | 0.00 USD | deriv |
| 15 Jun 2024 | EXERCISE | ANAPTYSBIO, INC | 4,534 | 0.00 USD | |
| 15 Jun 2024 | EXERCISE | ANAPTYSBIO, INC | 1,300 | 0.00 USD | deriv |
| 15 Jun 2024 | EXERCISE | ANAPTYSBIO, INC | 3,234 | 0.00 USD | deriv |